Salvia divinorum: A psychopharmacological riddle and a mind-body prospect

Current Drug Abuse Reviews

Volumn 6, Issue 1, 2013, Pages 43-53

  Díaz, José Luis ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Consciousness altering drugs; Ethnopharmacology; Kappa opioid receptor agonist; Mazatec shamanism; Mechanism of action; Mind body problem; Salvia divinorum; Salvinorin

Indexed keywords

SALVINORIN A;

ARTICLE; COCAINE DEPENDENCE; DEPERSONALIZATION; DIZZINESS; DRUG MECHANISM; DYSPHORIA; ETHNOBOTANY; ETHNOPHARMACOLOGY; HUMAN; NERVE CELL NETWORK; NONHUMAN; PAIN; PHYTOCHEMISTRY; PLANT LEAF; PRIORITY JOURNAL; PROPRIOCEPTION; PSYCHOPHARMACOLOGY; RETINA IMAGE; SALVIA DIVINORUM; TACTILE DISCRIMINATION;

BRAIN; DITERPENES, CLERODANE; DRUGS, CHINESE HERBAL; ETHNOBOTANY; HUMANS; MIND-BODY RELATIONS, METAPHYSICAL; RECEPTORS, OPIOID, KAPPA;

EID: 84880158508     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/18744737112059990004     Document Type: Article

References (39)

1. Wasson RG, Cowan G, Cowan F, Rhodes W. María sabina and her mazatec mushroom velada. Harcourt Brace Jovanovich; 1974.
2. Johnson JB. The elements of mazatec witchcraft. Göteborg Etnografiska Museum Ethnologiska Studier ed. 1939.
3. Reko BP. Mitobotánica zapoteca. General León 9; 1945.
4. Weitlaner RJ. Curaciones mazatecas. Anales Del Museo Nacional De México 1952(4): 279-85.
5. Epling C, Játiva-M CD. A new species of salvia from mexico. Botanical Museum Leaflets Harvard University 1962; 20(3): 75-6.
6. Wasson RG. A new mexican psychotropic drug from the mint family. Botanical Museum Leaflets Harvard University 1962; 20(3): 77-84.
7. Diaz JL. Etnofarmacología de plantas alucinógenas latinoamericanas. In: Diaz JL, editors. Etnofarmacología de plantas alucinógenas psicotrópicas latinoamericanas. Mexico: Cuadernos Científicos del Centro Mexicano de Estudios en Farmacodependencia; 1975. p. 135-201.
8. Valdes LJ, Diaz JL, Paul AG. Studies of salvia divinorum (lamiaceae), an hallucinogenic mint from the sierra mazateca in oaxaca, central mexico. Economic Botany 1983; 41(2): 283-91.
9. Schultes RE, Hofmann A. Plants of the gods: Origins of hallucinogenic use. New York: A. van der Marck Editions; 1987.
10. Schultes RE, Hofmann A. The botany and chemistry of hallucinogens. Springfield, Ill.: Thomas; 1980.
11. Fagetti A. Iniciaciones, trances, sueños--: Investigaciones sobre el chamanismo en méxico. Instituto de Ciencias Sociales y Humanidades Alfonso Velez Pliego Buap; 2010.
12. De la Garza M. Sueño y alucinación en el mundo nahuatl y maya. illustrated ed. México, D.F.: UNAM; 1990.
13. Ortega A, Blount JF, Manchand PS. Salvinorin, A new transneoclerodane diterpene from salvia divinorum (labiatae). J. Chem. Soc., Perkin Trans. 1 1982(0): 2505-8.
14. Valdes III LJ, Butler WM, Hatfield GM, Paul AG, Koreeda M., Divinorin A, A psychotropic terpenoid, and divinorin B from the hallucinogenic mexican mint, salvia divinorum. J. Org. Chem 1984; 49(24): 4716-20.
15. Díaz JL. Ethnopharmacology of sacred psychoactive plants used by the indians of mexico. Annu Rev Pharmacol Toxicol 1977; 17(1): 647-75.
16. Díaz JL. Ethnopharmacology and taxonomy of mexican psychodysleptic plants. J Psychoactive Drugs 1979; 11(1-2): 71-101.
17. Siebert DJ., Salvia divinorum and salvinorin A: New pharmacologic findings. J Ethnopharmacol 1994; 43(1): 53-6.
18. Ott J. Ethnopharmacognosy and human pharmacology of salvia divinorum and salvinorin A. Curare 1995; 18(1): 103-29.
19. Weil A. Pharmacology of consciousness: A narrative of subjective experience. In: Hammeroff SR, Kaszniak AW, Scott AC, editors. Toward a Science of Consciousness. Cambridge, Massachusett: MIT Press; 1996. p. 677-89.
20. Diaz JL. The stream revisited: A process model of phenomenological consciousness. In: Hammeroff SR, Kaszniak AW, Scott AC, editors. Toward a Scientific Basis of Consciousness. Cambridge, Massachusett: MIT Press; 1996. p. 713-24.
21. Valdés LJ. Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. J Psychoactive Drugs 1994; 26(3): 277-83.
22. González D, Riba J, Bouso JC, Gómez-Jarabo G, Barbanoj MJ. Pattern of use and subjective effects of salvia divinorum among recreational users. Drug Alcohol Depend 2006; 85(2): 157-62.
23. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, et al. Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 2002; 99(18): 11934-9.
24. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, et al. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: Structural and functional considerations. J Pharmacol Exp Ther 2004; 308(3): 1197-203.
25. Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science 2009; 323(5916): 934-7.
26. Knoll AT, William AAC. Dynorphin, stress, and depression. Brain Res. 2010; 1314(0): 56-73.
27. Pfeiffer A, Brantl V, Herz A, Emrich HM. Psychotomimesis mediated by kappa opiate receptors. Science 1986; 233(4765): 774-6.
28. Braida D, Limonta V, Pegorini S, Zani A, Guerini-Rocco C, Gori E, Sala M. Hallucinatory and rewarding effect of salvinorin A in zebrafish: Kappa-opioid and cb1-cannabinoid receptor involvement. Psychopharmacology (Berl) 2007; 190(4): 441-8.
29. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ. Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav 2006; 83(1): 109-13.
30. Potter DN, Damez-Werno D, Carlezon WA, Cohen BM, Chartoff EH. Repeated exposure to the opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity. Biol Psychiatry 2011; 70(8): 744-53.
31. Huxley A. The doors of perception: And heaven and hell. Vintage Digital; 2010.
32. Paz O. Conocimiento, drogas, inspiración. In: Obras completas volumen 2: Excursiones/Incursiones: dominio extranjero. Mexico: Fondo de Cultura Economica. p. 238-72.
33. Díaz JL. La conciencia viviente. Mexico: Fondo de Cultura Economica; 2007.
34. DePaoli AM, Hurley KM, Yasada K, Reisine T, Bell G. Distribution of kappa opioid receptor mrna in adult mouse brain: An in situ hybridization histochemistry study. Mol Cell Neurosci 1994; 5(4): 327-35.
35. Nieto D. Psicosis experimentales. Efectos psíquicos del hongo stropharia cubensis de oaxaca. Neurol. Neurocir. y Psiquiat 1959; 1: 6-12.
36. Nieto D. Psicosis experimentales con psilocibina. Neurol. Neurocir. y Psiquiat 1962; 3: 140-6.
37. Varela FJ. Neurophenomenology: A methodological remedy for the hard problem. J Conscious Stud 1996; 3(4): 330-49.
38. Díaz JL, Paniagua R, Diez-Martínez E. El texto fenomenologico corno objeto de análisis de procesos conscientes. Salud Mental 1998; 21(1): 14.
39. Dobkin de Rios M. Una teoría transcultural del uso de los alucinógenos de origen vegetal. Am Indíg 1977; 37(2): 251-304.